Measles, mumps, and rubella (MMR) are highly contagious viral diseases that were once common childhood illnesses. Thanks to vaccination, these diseases have become much less frequent in many parts of the world. However, outbreaks continue to occur, particularly in communities with lower vaccination rates and among international travelers.
Understanding how these diseases spread, recognizing their complications, and knowing who should receive the MMR vaccine are essential for protecting both individuals and communities.
Measles, mumps, and rubella are spread through respiratory droplets when an infected person coughs, sneezes, or breathes near others.
People who are most vulnerable include:
Although vaccination rates remain high overall, approximately 1 in 10 children in the United States do not receive the MMR vaccine, often because parents decline immunization. Lower vaccination rates increase the risk of outbreaks and reduce community (herd) immunity.
Measles is often thought of as a childhood rash illness, but it is actually a severe systemic infection that can lead to life-threatening complications.
Some of the most important complications include:
Children younger than 5 years of age are at the greatest risk for developing severe complications.
Mumps is best known for causing painful swelling of the salivary glands, particularly the parotid glands. While many people recover completely, the virus can cause several significant complications.
One of the most well-known is orchitis, or inflammation of the testicles, which occurs primarily in males after puberty and may reduce fertility.
Other potential complications include:
Although serious complications are uncommon, vaccination remains the best way to prevent infection.
Rubella usually causes a mild illness lasting only three to five days, and many people recover without complications.
However, infection during pregnancy can have devastating consequences. Rubella can cross the placenta and cause Congenital Rubella Syndrome (CRS), leading to severe birth defects affecting the baby’s heart, eyes, ears, and brain.
Because rubella poses its greatest threat to unborn babies, maintaining high vaccination rates throughout the community is essential to protect pregnant individuals through herd immunity.
The standard MMR vaccine contains live attenuated (weakened) viruses that stimulate long-lasting immunity without causing disease in healthy individuals.
Another available option is the MMRV vaccine, which combines protection against measles, mumps, rubella, and varicella (chickenpox). This vaccine is approved for children between 12 months and 12 years of age.
The routine childhood vaccination schedule includes two doses:
The second dose may be given earlier if it is administered at least 28 days after the first dose.
Infants between 6 and 11 months who will be traveling internationally should receive one early dose of the MMR vaccine before departure.
However, this early dose does not count toward the routine childhood series. After turning one year old, the child must still receive the standard two-dose series, with doses separated by at least 28 days.
Adults without evidence of immunity should receive at least one dose of the MMR vaccine.
Adults born in 1957 or earlier are generally considered naturally immune because they were likely exposed to the viruses before widespread vaccination.
If immunity cannot be confirmed, healthcare providers may recommend two doses administered at least 28 days apart.
During active measles or mumps outbreaks, public health authorities may recommend an additional booster dose, even for some individuals who have already completed the routine vaccination series.
Because the MMR vaccine contains live attenuated viruses, there are certain situations in which it should not be administered.
The vaccine is contraindicated in individuals with a history of severe allergic reactions (anaphylaxis) to neomycin or gelatin, which are vaccine components.
Pregnant individuals should not receive the MMR vaccine during pregnancy because of the theoretical risk associated with the live attenuated rubella virus. Although this risk has never been proven, vaccination is postponed until after pregnancy as a precaution.
The vaccine is safe during breastfeeding, and lactation is not a contraindication.
Most side effects are mild and temporary, including soreness at the injection site, a mild rash, or a sore throat.
One of the most persistent myths surrounding the MMR vaccine is the claim that it causes autism.
Extensive scientific research has demonstrated that there is no link between the MMR vaccine and autism. The original 1998 study that suggested a connection has been thoroughly discredited, and numerous large, well-designed studies have consistently found no association.
Another common misconception involves thimerosal, a mercury-containing preservative. MMR vaccines licensed in the United States do not contain thimerosal, and concerns about mercury exposure from the vaccine are unfounded.
The MMR vaccine has dramatically reduced cases of measles, mumps, and rubella worldwide, preventing countless hospitalizations, lifelong disabilities, and deaths. While these diseases may seem uncommon today, they remain only a plane ride away. Maintaining high vaccination rates protects not only individuals but also infants, pregnant women, and others who cannot be vaccinated themselves.
Staying up to date with the recommended MMR vaccination schedule remains one of the safest and most effective ways to protect yourself, your family, and your community.
